Cargando…
Phosphate control in reducing FGF23 levels in hemodialysis patients
BACKGROUND: In hemodialysis patients, high levels of Fibroblast Growth Factor 23 (FGF23) predict mortality. Our study was designed to test whether the control of serum phosphate is associated with a reduction in serum FGF23 levels. Additionally other variables with a potential effect on FGF23 levels...
Autores principales: | Rodelo-Haad, Cristian, Rodríguez-Ortiz, Maria E., Martin-Malo, Alejandro, Pendon-Ruiz de Mier, M. Victoria, Agüera, M. Luisa, Muñoz-Castañeda, Juan R., Soriano, Sagrario, Caravaca, Francisco, Alvarez-Lara, M. Antonia, Felsenfeld, Arnold, Aljama, Pedro, Rodriguez, Mariano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080760/ https://www.ncbi.nlm.nih.gov/pubmed/30086150 http://dx.doi.org/10.1371/journal.pone.0201537 |
Ejemplares similares
-
FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019) -
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
por: Muñoz-Castañeda, Juan Rafael, et al.
Publicado: (2020) -
Assessment of Inorganic Phosphate Intake by the Measurement of the Phosphate/Urea Nitrogen Ratio in Urine
por: Pendón-Ruiz de Mier, María Victoria, et al.
Publicado: (2021) -
Predicting mortality in hemodialysis patients using machine learning analysis
por: Garcia-Montemayor, Victoria, et al.
Publicado: (2020) -
Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
por: Arenas, Maria Dolores, et al.
Publicado: (2020)